JULIA BIANCALANA COSTA

(Fonte: Lattes)
Índice h a partir de 2011
3
Projetos de Pesquisa
Unidades Organizacionais
LIM/34 - Laboratório de Ciências da Reabilitação, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • article 6 Citação(ões) na Scopus
    Comparação da performance de fala em indivíduos gagos e fluentes
    (2017) COSTA, Julia Biancalana; RITTO, Ana Paula; JUSTE, Fabiola Staróbole; ANDRADE, Claudia Regina Furquim de
    ABSTRACT Purpose The aim of this study was to compare the speech performance of fluent speakers and individuals who stutter during spontaneous speech, automatic speech, and singing. Methods The study sample was composed of 34 adults, 17 individuals who stutter and 17 fluent controls, matched for gender and age. The speech performance of participants was compared by means of three tasks: monologue, automatic speech, and singing. The following aspects were assessed: total number of common disruptions and total number of stuttering-like disruptions. Results Statistically significant difference was observed only for the monologue task in both intra- and inter-group comparisons. Conclusion The outcomes of this study indicate that tasks of higher motor and melodic complexities, such as the monologue task, negatively affect the speech fluency of both fluent speakers and individuals who stutter.
  • article
    A influência da hereditariedade na ocorrência de variáveis preditoras na gagueira crônica do desenvolvimento
    (2021) PINTO, Giovanna Cardoso; JUSTE, Fabiola; COSTA, Julia Biancalana; RITTO, Ana Paula; ANDRADE, Claudia Regina Furquim de
    ABSTRACT Purpose To test if the variable family heredity for chronic developmental stuttering (CDS) is a direct predictor of the speech fluency outcome in children. Methods Participants of the study were 200 children, between 2 and 12 years of age, of both genders, with no racial and socioeconomic distinction, diagnosed with a complaint of CDS, and with no language and/or hearing comorbidity, over a period of 5 years. Participants were divided in three study groups (low risk for CDS, moderate risk for CDS, and high risk for CDS) according to the risk indicators determined by the Risk Protocol for Developmental Stuttering. In order to determine the control variable (positive heredity for stuttering), we considered the participant as being affected if he/she presented a first-degree family member (father, mother, siblings) who self-declared themselves as a person who stuttered. All of the participants were assessed according to Risk Protocol for Developmental Stuttering and to The Speech Fluency Profile Assessment. Results No significant difference was observed for the demographic variables and for the results on The Fluency Profile Assessment among the groups with mild, moderate and high risk of stuttering when comparing the groups with positive and negative family heredity. Conclusion The variable family heredity did not indicate the risk level for the manifestation of stuttering and also did not identify those at risk of presenting CDS.
  • article 0 Citação(ões) na Scopus
    Treatment clinical trial - three types - for children with fluency disorders and stuttering
    (2022) AVILA, Nathalia dos Santos Fernandes de; JUSTE, Fabiola; COSTA, Julia Biancalana; ANDRADE, Claudia Regina Furquim de
    Purpose: To present a treatment clinical trial, involving three types of treatment for chronic developmental stuttering (CDS), to verify whether they present indicators and sufficient information to establish an effective and safe benefit-risk relationship. Methods: The study included 252 children between 2 and 12 years old, who underwent assessment and treatment for CDS. Among the selected children, 93 met the established inclusion criteria. After obtaining the scores for the risk of CDS (Protocol for the Risk of Developmental Stuttering), all children were assessed according to their fluency profile and the severity level of stuttering. The children underwent treatment for CDS Green, Yellow and Red Programs. The treatment chosen for each child was based on the analysis of the risk for CDS. Results: All therapeutic programs presented positive results in the post-treatment assessment considering the analyzed parameters, with the exception of word repetition, sound prolongation at the end of words, and intrusion of sounds/word segments. Conclusion: The tested therapeutic programs - green, yellow, and red - were efficient for most of the participants. The direct intervention used in the Red Program was highly efficient in promoting fluent speech. This result suggests that for most of the patients with a higher risk of developing the chronic form of stuttering, the use of specific fluency promotion techniques is indicated.